SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Concern about staged IPO share unlocks and insider selling is weighing on Cerebras, alongside reports that OpenAIs latest ultrafast model runs on Nvidia GPUs rather than Cerebras hardware. Bulls debate the significance, citing Cerebras inference technology and other customer deals, while skeptics focus on potential selling pressure and the companys OpenAI exposure.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

A sharp, high-volume rally without a confirmed company announcement is driving attention, with traders debating whether institutional buying and short covering are behind the move or whether it could fade without news. Bulls also point to Anktivas growth and anticipated FDA label-expansion decision as potential catalysts, while speculation about leaked news remains unconfirmed.

Vistra Corp. is a holding company, which engages in the provision of electricity and power generation. It operates through the following segments: Retail, Texas, East, West, and Asset Closure. The Retail segment includes sale of electricity and natural gas to residential, commercial, and industrial customers. The Texas and East segments are involved in electricity generation, wholesale energy sales and purchases, commodity risk management activities, fuel production and fuel logistics management. The West segment represents the company's electricity generation operations in CAISO. The Asset Closure segment refers to the decommissioning and reclamation of retired plants and mines. The company was founded in 1882 and is headquartered in Irving, TX.

Vistra Corp

A reported federal loan to fund upgrades and expand capacity at three Vistra nuclear plants is drawing attention, against a backdrop of rising electricity demand from data centers. Traders largely view the proposal as bullish for Vistras nuclear and power-demand outlook, though some question why the share price remains volatile and whether the financing is as positive as hoped.

Armada Acquisition Corp. II is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combinations with one or more businesses. The company was founded on October 3, 2024 and is headquartered in Miami, FL.

Armada Acquisition Corp. II - Ordinary Shares- Class A

Evernorth Holdings Inc.

Evernorths shareholder-approved business combination with Armada II and its planned Nasdaq debut as an XRP-treasury company are driving a sharp speculative rally. Bulls focus on the anticipated XRP holdings and tight-float dynamics, while skeptics question the valuation relative to the XRP backing and warn of profit-taking and merger-related volatility.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

A cluster of insider purchases, including additional buying by CEO Ryan Cohen and director Nat Turner, is driving attention to GameStop. Many traders see the buying as a bullish signal and speculate about a squeeze, while others argue it has not produced a sustained breakout and that the company needs substantive business news.

MaxLinear, Inc. engages in the provision of communications systems-on-chip (SoC) solutions used in broadband, mobile and wireline infrastructure, data center, and industrial and multi-market applications. Its products include cable broadband modems and gateways, wireline connectivity devices, radio frequency transceivers, fiber-optic modules, video set-top boxes and gateways, hybrid analog and digital televisions, direct broadcast satellite outdoor and indoor units, and power management and interface products. The company was founded by Kimihiko Imura, Curtis C. Ling, and Kishore V. Seendripu on September 25, 2003 and is headquartered in Carlsbad, CA.

MaxLinear Inc

MXLs sharp advance is drawing attention amid a broad semiconductor rally, with traders pointing to the jobs report and momentum buying rather than a confirmed company-specific catalyst. Bulls are celebrating the breakout, while others warn the move may be overextended and question whether it can hold its gains.

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

New RAMP 201 analyses for Verastems avutometinibdefactinib combination in recurrent low-grade serous ovarian cancer are drawing attention, with traders highlighting activity in KRAS wild-type patients and comparisons favoring the regimen over conventional care. Some see the findings as expanding the treatment opportunity, while others are frustrated by the muted share-price response and are looking ahead to the VS-7375 clinical update.

AGNC Investment Corp. engages in the operation of a real estate investment trust. The firm invests in residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by the United States government-sponsored enterprise or by the United States government agency. It also invests in other types of mortgage and mortgage-related securities, such as credit risk transfer securities and non-Agency residential and commercial mortgage-backed securities, where repayment of principal and interest is not guaranteed by the United States government-sponsored enterprise or by the United States Government agency, and other assets related to the housing, mortgage, or real estate markets. The company was founded on January 7, 2008 and is headquartered in Bethesda, MD.

AGNC Investment Corp

Rising Treasury yields and expectations of persistently high rates are weighing on AGNC and other mortgage REITs, with traders pointing to pressure on mortgage-backed securities and the companys book value. Income-focused investors are buying the pullback for its monthly dividend, while others worry about further declines and possible dividend cuts.

Corteva, Inc. is a global pure-play agriculture company that combines innovative technologies, high-touch customer engagement and operational execution to profitably deliver solutions for the world's most pressing agriculture challenges. It generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. The company leverages recognized agricultural brands and a robust technology pipeline to maximize productivity for farmers while working with stakeholders throughout the food system to fulfill its promise of enriching the lives of those who produce and those who consume, ensuring progress for generations to come. Corteva was founded in 1802 and is headquartered in Indianapolis, IN.

Corteva Inc

Cortevas completed spin-off of its seed business into Vylor has left CTVA as a standalone crop-protection company, prompting a volatile repricing and widespread confusion over the apparent collapse in its share price. Traders debate whether the additional selling reflects post-spin and index-related flows or a fair valuation of the remaining business, with some calling it oversold and others warning it could fall further.

The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and décor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and rental equipment. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978 and is headquartered at Atlanta, GA.

Home Depot, Inc.

Home Depots extended decline and repeated multi-year or 52-week lows dominate discussion, with traders linking the weakness to high mortgage rates and soft housing and renovation demand. Some see oversold levels as a buying opportunity, while others expect further downside until the housing backdrop improves.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Precigens accelerating PAPZIMEOS launch and strong quarterly results are driving discussion, with traders citing commercial execution and the prospect of cash-flow breakeven as reasons for optimism. Many also speculate about a short squeeze, a possible pharma acquisition, and upcoming European and cancer-trial milestones, though those outcomes remain uncertain.

4 Low-Beta Healthcare Stocks to Buy Amid Fears of Another Rate Hike

ABT, CORT, PGEN and BHC offer low-beta healthcare exposure as rate-hike fears and market volatility persist.

UTHR Prevails in LQDA's Yutrepia Patent Dispute, Stock Up Nearly 13%

United Therapeutics secures a key patent ruling against Liquidia, potentially limiting Yutrepia's PH-ILD use and reducing competition for its Tyvaso products.

Precigen (PGEN) Soars 6.3%: Is Further Upside Left in the Stock?

Precigen (PGEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

NVO's Ozempic Outshines LLY's Mounjaro in Lowering Cardiovascular Risk

Novo's real-world study finds that patients who increase their Ozempic to 2 mg have a lower observed MACE risk than those who switch to Mounjaro.

uniQure Plunges on Additional Data From Huntington's Disease Study

QURE's Huntingtons gene therapy shows sustained functional benefits at 36 months, but mixed 48-month data add uncertainty. 

PGEN vs. IRWD: Which Biotech Stock Offers Better Growth Potential?

Precigen's Papzimeos and Ironwood's Linzess are driving growth, but competition, pipeline progress and single-product reliance shape each biotech's outlook.

IOVA Stock Hits 52-Week High on Raised Revenue Outlook for 2026

Iovance hits a 52-week high after raising its 2026 revenue outlook to $410-$420 million on strong demand for its marketed therapies.

Here's Why You Should Add URGN Stock to Your Portfolio Now

UroGen's Zusduri sales surge, Jelmyto revenues and advancing pipeline assets strengthen its shift toward a commercial growth story.

AbbVie Wins FDA Nod for New Parkinson's Disease Drug Juvmo

ABBV wins FDA approval for Juvmo, expanding its Parkinson's portfolio with a once-daily oral treatment and potential $5B-plus PD opportunity.

KOD Stock Soars 178% on Positive Wet AMD Data as BLA Filing Nears

Kodiak surges 178% as positive phase III DAYBREAK data show Zenkuda and tabirafusp-ted met key endpoints against Eylea.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

MRNA, PGEN Stocks Hit Multi-Year Highs – What’s Driving The Momentum Today?

Equity

Bullish Sentiment

Up more than 5%

Flat to up 5%

Flat to down 5%

Down more than 5%

What&#39;s your expected total return for the S&amp;P 500 ($SPY) in Q4? 

Drop your reasoning in the comments.

Stocktwits

What's your expected total return for the S&P 500 (

) in Q4? 

Drop your reasoning in the comments.

Current Price	$8.54
Prev Close	$8.21
Open	$8.30
Dividend Yield	0.00%
50-Day Moving Average	$6.97
Beta	1.71
Avg. Volume	4.67M
PE Ratio	-7.47

52-Week High	$8.98
52-Week Low	$2.99
Market Capitalization	$2.94B
EPS (Annual)	-$1.37
Price to Book	67.45
Revenue Per Employee	$60,525.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

PGEN Fundamentals